Trials / Conditions / Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8
Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8
3 registered clinical trials studyying Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer NCT06959641 | Northwestern University | Phase 2 |
| Active Not Recruiting | Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced NCT04514484 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refract NCT04061980 | Providence Health & Services | Phase 2 |